Yeela Talmor-Barkan, Jiao Yu, Nancy-Sarah Yacovzada, Nili Schamroth Pravda, Colby Ayers, James A de Lemos, W H Wilson Tang, Stanley L Hazen, Alon Eisen, Guy Witberg, Ran Kornowski, Ian J Neeland
OBJECTIVE: To evaluate the association between trimethylamine N-oxide (TMAO) and related metabolites with adverse cardiovascular events in a multiethnic urban primary prevention population. METHODS: We performed a case-control study of 361 participants of the Dallas Heart Study, including 88 participants with an incident atherosclerotic cardiovascular disease (ASCVD) event and 273 controls matched for age, sex, and body mass index without an ASCVD event during 12 years of follow-up (January 1, 2000, through December 31, 2015)...
April 26, 2024: Mayo Clinic Proceedings